Company Proteo, Inc. Other OTC
Equities
PTEO
US74369R3084
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Oliver Wiedow
CEO | Chief Executive Officer | 66 | 00-11-30 |
Juergen Paal
COO | Chief Operating Officer | 53 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Oliver Wiedow
CEO | Chief Executive Officer | 66 | 00-11-30 |
Hartmut Weigelt
BRD | Director/Board Member | 74 | 00-11-30 |
Jork von Reden
BRD | Director/Board Member | 80 | 18-11-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 130,000 | 0 | 0 | 0.1502 % |
Stock B | 1 | 3,338 | 1,092 ( 32.71 %) | 0 | |
Stock C | 0 | 723,590 | 0 | 0 |
Company contact information
Proteo, Inc.
2102 Business Center Drive
92612, Irvine
+
Sector
1st Jan change | Capi. | |
---|---|---|
+21.56% | 45.01B | |
+47.19% | 40.96B | |
-5.71% | 38.62B | |
+35.03% | 32.6B | |
-8.34% | 27.49B | |
+17.74% | 27.17B | |
+48.94% | 14.61B | |
+40.97% | 12.95B | |
-2.46% | 11.36B |